Follow
Argyro Syngelaki
Argyro Syngelaki
Senior Lecturer and Consultant Midwife in Fetal Medicine, King's College Hospital
Verified email at nhs.net
Title
Cited by
Cited by
Year
Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia
DL Rolnik, D Wright, LC Poon, N O’Gorman, A Syngelaki, ...
New England Journal of Medicine 377 (7), 613-622, 2017
20042017
Competing risks model in early screening for preeclampsia by biophysical and biochemical markers
R Akolekar, A Syngelaki, L Poon, D Wright, KH Nicolaides
Fetal diagnosis and therapy 33 (1), 8-15, 2013
7102013
Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks
R Akolekar, A Syngelaki, R Sarquis, M Zvanca, KH Nicolaides
Prenatal diagnosis 31 (1), 66-74, 2011
6952011
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation
N O’Gorman, D Wright, A Syngelaki, R Akolekar, A Wright, LC Poon, ...
American journal of obstetrics and gynecology 214 (1), 103. e1-103. e12, 2016
6332016
Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks
A Syngelaki, T Chelemen, T Dagklis, L Allan, KH Nicolaides
Prenatal diagnosis 31 (1), 90-102, 2011
5892011
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
KH Nicolaides, A Syngelaki, G Ashoor, C Birdir, G Touzet
American journal of obstetrics and gynecology 207 (5), 374. e1-374. e6, 2012
5742012
Maternal age and adverse pregnancy outcome: a cohort study
A Khalil, A Syngelaki, N Maiz, Y Zinevich, KH Nicolaides
Ultrasound in Obstetrics & Gynecology 42 (6), 634-643, 2013
5542013
Fetal fraction in maternal plasma cell‐free DNA at 11–13 weeks' gestation: relation to maternal and fetal characteristics
G Ashoor, A Syngelaki, LCY Poon, JC Rezende, KH Nicolaides
Ultrasound in Obstetrics & Gynecology 41 (1), 26-32, 2013
5482013
Competing risks model in screening for preeclampsia by maternal characteristics and medical history
D Wright, A Syngelaki, R Akolekar, LC Poon, KH Nicolaides
American journal of obstetrics and gynecology 213 (1), 62. e1-62. e10, 2015
4672015
ASPRE trial: performance of screening for preterm pre‐eclampsia
DL Rolnik, D Wright, LCY Poon, A Syngelaki, N O'Gorman, ...
Ultrasound in obstetrics & gynecology 50 (4), 492-495, 2017
4502017
Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18
G Ashoor, A Syngelaki, M Wagner, C Birdir, KH Nicolaides
American journal of obstetrics and gynecology 206 (4), 322. e1-322. e5, 2012
4492012
Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations
N O'Gorman, D Wright, LC Poon, DL Rolnik, A Syngelaki, ...
Ultrasound in Obstetrics & Gynecology 49 (6), 756-760, 2017
3882017
Validation of targeted sequencing of single‐nucleotide polymorphisms for non‐invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y
KH Nicolaides, A Syngelaki, M Gil, V Atanasova, D Markova
Prenatal diagnosis 33 (6), 575-579, 2013
3682013
Metformin versus placebo in obese pregnant women without diabetes mellitus
A Syngelaki, KH Nicolaides, J Balani, S Hyer, R Akolekar, R Kotecha, ...
New England Journal of Medicine 374 (5), 434-443, 2016
3372016
Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
MY Tan, A Syngelaki, LC Poon, DL Rolnik, N O'Gorman, JL Delgado, ...
Ultrasound in Obstetrics & Gynecology 52 (2), 186-195, 2018
3342018
Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
MY Tan, D Wright, A Syngelaki, R Akolekar, S Cicero, D Janga, M Singh, ...
Ultrasound in Obstetrics & Gynecology 51 (6), 743-750, 2018
3182018
A competing risks model in early screening for preeclampsia
D Wright, R Akolekar, A Syngelaki, LCY Poon, KH Nicolaides
Fetal diagnosis and therapy 32 (3), 171-178, 2012
3092012
Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks
S Nanda, M Savvidou, A Syngelaki, R Akolekar, KH Nicolaides
Prenatal diagnosis 31 (2), 135-141, 2011
2922011
Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
N O'Gorman, D Wright, LC Poon, DL Rolnik, A Syngelaki, A Wright, ...
Ultrasound in obstetrics & gynecology 49 (6), 751-755, 2017
2722017
Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation
LCY Poon, NA Zymeri, A Zamprakou, A Syngelaki, KH Nicolaides
Fetal diagnosis and therapy 31 (1), 42-48, 2012
2722012
The system can't perform the operation now. Try again later.
Articles 1–20